Recursion Pharmaceuticals Inc (RXRX) Insider Trading
- $2,787,850.00
- $33,045,427.62
- Nov. 13, 2024
- Blake Borgeson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 13, 2024 | CFO | 15,000 | $7.66 | Sell | $114,900.00 | |
Nov. 12, 2024 | Director | 11,447 | $7.64 | Sell | $87,455.08 | |
Oct. 29, 2024 | Director | 11,447 | $6.72 | Sell | $76,923.84 | |
Oct. 24, 2024 | COO | 6,000 | $6.31 | Sell | $37,860.00 | |
Oct. 15, 2024 | Director | 11,447 | $6.67 | Sell | $76,351.49 | |
Oct. 8, 2024 | CFO | 15,000 | $6.32 | Sell | $94,800.00 | |
Oct. 2, 2024 | CEO | 20,000 | $6.16 | Sell | $123,200.00 | |
Oct. 1, 2024 | Director | 11,447 | $6.22 | Sell | $71,200.34 | |
Sept. 26, 2024 | COO | 6,000 | $7.00 | Sell | $42,000.00 | |
Sept. 17, 2024 | Director | 11,447 | $6.84 | Sell | $78,297.48 | |
Sept. 10, 2024 | CFO | 15,000 | $6.17 | Sell | $92,550.00 | |
Sept. 4, 2024 | CEO | 20,000 | $6.04 | Sell | $120,800.00 | |
Sept. 3, 2024 | Director | 11,447 | $6.27 | Sell | $71,772.69 | |
Aug. 29, 2024 | COO | 6,000 | $7.56 | Sell | $45,360.00 | |
Aug. 20, 2024 | Director | 11,447 | $7.12 | Sell | $81,502.64 | |
Aug. 13, 2024 | CFO | 15,000 | $6.35 | Sell | $95,250.00 | |
Aug. 7, 2024 | CEO | 30,000 | $7.10 | Sell | $213,000.00 | |
Aug. 6, 2024 | Director | 11,447 | $6.82 | Sell | $78,068.54 | |
July 25, 2024 | COO | 6,000 | $8.13 | Sell | $48,780.00 | |
July 23, 2024 | Director | 11,447 | $8.48 | Sell | $97,070.56 | |
July 10, 2024 | CEO | 50,000 | $7.48 | Sell | $374,000.00 | |
July 9, 2024 | Director | 11,447 | $7.32 | Sell | $83,792.04 | |
July 9, 2024 | CFO | 15,000 | $7.32 | Sell | $109,800.00 | |
June 27, 2024 | COO | 6,000 | $7.21 | Sell | $43,260.00 | |
June 25, 2024 | Director | 11,447 | $9.51 | Sell | $108,860.97 | |
June 13, 2024 | CFO | 15,000 | $9.32 | Sell | $139,800.00 | |
June 11, 2024 | Director | 11,447 | $8.45 | Sell | $96,727.15 | |
June 5, 2024 | CEO | 50,000 | $8.42 | Sell | $421,000.00 | |
May 30, 2024 | COO | 3,000 | $8.78 | Sell | $26,340.00 | |
May 28, 2024 | Director | 11,447 | $9.17 | Sell | $104,968.99 | |
May 1, 2024 | CEO | 50,000 | $7.73 | Sell | $386,500.00 | |
April 30, 2024 | Director | 11,447 | $7.95 | Sell | $91,003.65 | |
April 25, 2024 | COO | 3,000 | $7.67 | Sell | $23,010.00 | |
April 17, 2024 | CFO | 23,124 | $7.58 | Sell | $175,279.92 | |
April 16, 2024 | Director | 11,447 | $7.66 | Sell | $87,684.02 | |
April 3, 2024 | CEO | 40,000 | $8.84 | Sell | $353,600.00 | |
April 2, 2024 | Director | 11,447 | $8.82 | Sell | $100,962.54 | |
March 28, 2024 | CEO | 40,000 | $10.10 | Sell | $404,000.00 | |
March 21, 2024 | COO | 8,000 | $10.75 | Sell | $86,000.00 | |
March 19, 2024 | Director | 20,054 | $10.79 | Sell | $216,382.66 | |
March 13, 2024 | CFO | 25,000 | $11.03 | Sell | $275,750.00 | |
March 6, 2024 | CEO | 36,319 | $11.86 | Sell | $430,743.34 | |
March 5, 2024 | Director | 20,054 | $12.06 | Sell | $241,851.24 | |
Feb. 22, 2024 | COO | 8,000 | $14.89 | Sell | $119,120.00 | |
Feb. 20, 2024 | Director | 20,054 | $12.32 | Sell | $247,065.28 | |
Feb. 13, 2024 | CFO | 25,000 | $9.86 | Sell | $246,500.00 | |
Feb. 7, 2024 | CEO | 48,272 | $9.22 | Sell | $445,067.84 | |
Feb. 6, 2024 | Director | 11,447 | $9.30 | Sell | $106,457.10 | |
Jan. 25, 2024 | COO | 8,000 | $10.35 | Sell | $82,800.00 | |
Jan. 23, 2024 | Director | 20,054 | $10.58 | Sell | $212,171.32 |
Insiders are both buying and selling Recursion Pharmaceuticals Inc stock.
The insider traders at Recursion Pharmaceuticals Inc are: Blake Borgeson, Christopher Gibson, Tina Marriott Larson, Michael Secora, Shafique Virani, Tina Marriott, Mubadala Investment Co Pjsc, Dean Y Li, Gibson Christopher, Terry-Ann Burrell, and Zavain Dar
The most active insider trader at Recursion Pharmaceuticals Inc is Blake Borgeson with 53 trades.
Christopher Gibson has sold the most Recursion Pharmaceuticals Inc stock with a total value of $18,575,217.95.
Mubadala Investment Co Pjsc has bought the most Recursion Pharmaceuticals Inc stock with a total value of $3,191,575.00.
The most recent insider trade for Recursion Pharmaceuticals Inc was on Nov. 13, 2024.
The single biggest insider buy for Recursion Pharmaceuticals Inc was from Mubadala Investment Co Pjsc with a total value of $730,795.32 on Feb. 21, 2023.
The single biggest insider sell for Recursion Pharmaceuticals Inc was from Christopher Gibson with a total value of $2,190,000.00 on March 7, 2022.